INS and type 2 diabetes mellitus: Interleukin-1β, an inducer of various pro-inflammatory cytokines and chemokines, was implicated in driving tissue inflammation during T2DM (40, 41), and was tightly associated with promoting β-cell death, impaired insulin sensitivity and enhancing the adhesion capacity of circulating monocytes to the vascular endothelium (42–44).